rs762898505
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4BP6BS1BS2
The NM_001349338.3(FOXP1):āc.13T>Cā(p.Ser5Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000784 in 1,389,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001349338.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXP1 | NM_001349338.3 | c.13T>C | p.Ser5Pro | missense_variant | 6/21 | ENST00000649528.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXP1 | ENST00000649528.3 | c.13T>C | p.Ser5Pro | missense_variant | 6/21 | NM_001349338.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000121 AC: 16AN: 132296Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000717 AC: 18AN: 251072Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135860
GnomAD4 exome AF: 0.0000740 AC: 93AN: 1257424Hom.: 0 Cov.: 37 AF XY: 0.0000882 AC XY: 55AN XY: 623602
GnomAD4 genome AF: 0.000121 AC: 16AN: 132296Hom.: 0 Cov.: 31 AF XY: 0.000128 AC XY: 8AN XY: 62496
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 27, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Reported in individual with intellectual disability who inherited variant from parent; however, variant also seen in matched controls and clinical information not provided on parents (Horn et al., 2010); This variant is associated with the following publications: (PMID: 20848658) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | FOXP1: PP3, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 29, 2014 | - - |
FOXP1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 30, 2023 | The FOXP1 c.13T>C variant is predicted to result in the amino acid substitution p.Ser5Pro. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-71247520-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at